Fulvestrant Patent Expiration
Fulvestrant is used for treating hormone receptor positive metastatic breast cancer in postmenopausal women. It was first introduced by Astrazeneca Pharmaceuticals Lp
Fulvestrant Patents
Given below is the list of patents protecting Fulvestrant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fulvestrant | US9271990 | Fulvestrant formulations | May 17, 2034 | Fresenius Kabi Usa |
| Fulvestrant | US10188663 | Fulvestrant formulations | Feb 14, 2034 | Fresenius Kabi Usa |
| Fulvestrant | US9833459 | Fulvestrant formulations | Feb 14, 2034 | Fresenius Kabi Usa |
| Faslodex |
US6774122 (Pediatric) | Formulation |
Jul 09, 2021
(Expired) | Astrazeneca |
| Faslodex |
US7456160 (Pediatric) | Formulation |
Jul 09, 2021
(Expired) | Astrazeneca |
| Faslodex |
US8329680 (Pediatric) | Formulation |
Jul 09, 2021
(Expired) | Astrazeneca |
| Faslodex |
US8466139 (Pediatric) | Formulation |
Jul 09, 2021
(Expired) | Astrazeneca |
| Faslodex | US6774122 | Formulation |
Jan 09, 2021
(Expired) | Astrazeneca |
| Faslodex | US7456160 | Formulation |
Jan 09, 2021
(Expired) | Astrazeneca |
| Faslodex | US8329680 | Formulation |
Jan 09, 2021
(Expired) | Astrazeneca |
| Faslodex | US8466139 | Formulation |
Jan 09, 2021
(Expired) | Astrazeneca |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Fulvestrant's patents.
Latest Legal Activities on Fulvestrant's Patents
Given below is the list recent legal activities going on the following patents of Fulvestrant.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 Jul, 2022 | US10188663 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Jun, 2021 | US9833459 |
| Patent Issue Date Used in PTA Calculation Critical
| 29 Jan, 2019 | US10188663 |
| Recordation of Patent Grant Mailed Critical
| 29 Jan, 2019 | US10188663 |
| Email Notification Critical
| 10 Jan, 2019 | US10188663 |
| Issue Notification Mailed Critical
| 09 Jan, 2019 | US10188663 |
| Application Is Considered Ready for Issue Critical
| 20 Dec, 2018 | US10188663 |
| Dispatch to FDC | 20 Dec, 2018 | US10188663 |
| Issue Fee Payment Verified Critical
| 17 Dec, 2018 | US10188663 |
| Issue Fee Payment Received Critical
| 17 Dec, 2018 | US10188663 |
Fulvestrant's Family Patents
